Owens & Minor (OMI) Competitors

$24.73
-0.69 (-2.71%)
(As of 04/30/2024 ET)

OMI vs. PDCO, PTCT, MRVI, GLPG, KROS, AMPH, BEAM, NAMS, GERN, and RNA

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), PTC Therapeutics (PTCT), Maravai LifeSciences (MRVI), Galapagos (GLPG), Keros Therapeutics (KROS), Amphastar Pharmaceuticals (AMPH), Beam Therapeutics (BEAM), NewAmsterdam Pharma (NAMS), Geron (GERN), and Avidity Biosciences (RNA). These companies are all part of the "medical" sector.

Owens & Minor vs.

Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, community ranking, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.36$207.56M$2.0312.81
Owens & Minor$10.33B0.19-$41.30M-$0.54-47.07

Patterson Companies currently has a consensus price target of $32.56, indicating a potential upside of 25.21%. Owens & Minor has a consensus price target of $23.29, indicating a potential downside of 8.40%. Given Owens & Minor's stronger consensus rating and higher probable upside, analysts clearly believe Patterson Companies is more favorable than Owens & Minor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

85.4% of Patterson Companies shares are owned by institutional investors. Comparatively, 98.0% of Owens & Minor shares are owned by institutional investors. 1.5% of Patterson Companies shares are owned by insiders. Comparatively, 2.6% of Owens & Minor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Patterson Companies has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.

Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.41% of users gave Patterson Companies an outperform vote while only 48.82% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
359
52.41%
Underperform Votes
326
47.59%
Owens & MinorOutperform Votes
249
48.82%
Underperform Votes
261
51.18%

Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.40%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.95% 20.98% 7.70%
Owens & Minor -0.40%11.62%2.03%

In the previous week, Patterson Companies had 2 more articles in the media than Owens & Minor. MarketBeat recorded 11 mentions for Patterson Companies and 9 mentions for Owens & Minor. Patterson Companies' average media sentiment score of 0.39 beat Owens & Minor's score of 0.14 indicating that Owens & Minor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
0 Very Positive mention(s)
4 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owens & Minor
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Patterson Companies beats Owens & Minor on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.92B$7.68B$4.81B$17.47B
Dividend YieldN/A2.35%5.32%3.54%
P/E Ratio-47.0717.87162.6020.94
Price / Sales0.191.172,528.0910.47
Price / Cash4.8911.1831.8915.39
Price / Book2.102.414.615.04
Net Income-$41.30M$249.27M$101.87M$963.13M
7 Day Performance-0.59%-0.30%-0.14%0.50%
1 Month Performance-8.26%-17.92%-7.59%-3.35%
1 Year Performance63.58%15.61%6.00%95.28%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.8336 of 5 stars
$25.97
+0.2%
$33.11
+27.5%
-4.1%$2.33B$6.47B12.797,600
PTCT
PTC Therapeutics
2.5494 of 5 stars
$25.41
-2.2%
$33.53
+32.0%
-41.7%$1.95B$937.82M-3.04988Earnings Report
Analyst Upgrade
Positive News
MRVI
Maravai LifeSciences
3.5665 of 5 stars
$7.72
+4.7%
$11.56
+49.7%
-43.1%$1.94B$288.95M-8.58650Short Interest ↑
News Coverage
GLPG
Galapagos
0.374 of 5 stars
$29.45
+1.3%
$34.50
+17.1%
-26.5%$1.94B$259.40M-12.861,123Upcoming Earnings
Short Interest ↑
KROS
Keros Therapeutics
2.0573 of 5 stars
$55.19
-1.1%
$86.00
+55.8%
+32.2%$1.99B$150,000.00-10.61136Upcoming Earnings
AMPH
Amphastar Pharmaceuticals
4.6849 of 5 stars
$40.91
+1.8%
$66.00
+61.3%
+17.5%$2.00B$644.40M15.861,761Short Interest ↑
BEAM
Beam Therapeutics
1.7486 of 5 stars
$23.47
-2.6%
$41.00
+74.7%
-28.2%$1.92B$377.71M-12.35436News Coverage
Gap Down
NAMS
NewAmsterdam Pharma
2.4853 of 5 stars
$21.45
+6.0%
$33.25
+55.0%
+52.2%$1.91B$14.09M0.0029News Coverage
GERN
Geron
3.5974 of 5 stars
$3.50
-6.2%
$5.33
+52.4%
+68.3%$1.91B$240,000.00-10.61141Upcoming Earnings
Analyst Report
Short Interest ↑
News Coverage
Gap Down
RNA
Avidity Biosciences
1.2653 of 5 stars
$25.14
+4.1%
$36.33
+44.5%
+99.2%$2.00B$9.56M-8.67253Positive News

Related Companies and Tools

This page (NYSE:OMI) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners